1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology in Japan

Biotechnology in Japan

  • November 2016
  • -
  • MarketLine
  • -
  • 36 pages

Summary
Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Japan

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Japan

- Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Japan biotechnology market with five year forecasts

Reasons To Buy
- What was the size of the Japan biotechnology market by value in 2016?

- What will be the size of the Japan biotechnology market in 2021?

- What factors are affecting the strength of competition in the Japan biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up Japan's biotechnology market?

Key Findings
The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

The Japanese biotechnology market is expected to generate total revenues of $32.2bn in 2016, representing a compound annual growth rate (CAGR) of 3% between 2012 and 2016.

The Environment and Industrial processing segment is expected to be the market's most lucrative in 2016, with total revenues of $12.5bn, equivalent to 38.9% of the market's overall value.

The Japanese government is investing into the biotechnology industry in response to rising pressure from China. Biotech in Japan has benefitted greatly from 'Abenomics' which pumped vast sums of money into the Japanese economy.

Table Of Contents

Biotechnology in Japan
Table of Contents
Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Astellas Pharma Inc.
Daiichi Sankyo Co., Ltd.
Mitsubishi Tanabe Pharma Corporation
Takeda Pharmaceutical Company Limited
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine


List of Tables
Table 1: Japan biotechnology industry value: $ billion, 2012-16(e)
Table 2: Japan biotechnology industry category segmentation: $ billion, 2016(e)
Table 3: Japan biotechnology industry geography segmentation: $ billion, 2016(e)
Table 4: Japan biotechnology industry value forecast: $ billion, 2016-21
Table 5: Astellas Pharma Inc.: key facts
Table 6: Astellas Pharma Inc.: key financials ($)
Table 7: Astellas Pharma Inc.: key financials (Â¥)
Table 8: Astellas Pharma Inc.: key financial ratios
Table 9: Daiichi Sankyo Co., Ltd.: key facts
Table 10: Daiichi Sankyo Co., Ltd.: key financials ($)
Table 11: Daiichi Sankyo Co., Ltd.: key financials (Â¥)
Table 12: Daiichi Sankyo Co., Ltd.: key financial ratios
Table 13: Mitsubishi Tanabe Pharma Corporation: key facts
Table 14: Mitsubishi Tanabe Pharma Corporation: key financials ($)
Table 15: Mitsubishi Tanabe Pharma Corporation: key financials (Â¥)
Table 16: Mitsubishi Tanabe Pharma Corporation: key financial ratios
Table 17: Takeda Pharmaceutical Company Limited: key facts
Table 18: Takeda Pharmaceutical Company Limited: key financials ($)
Table 19: Takeda Pharmaceutical Company Limited: key financials (Â¥)
Table 20: Takeda Pharmaceutical Company Limited: key financial ratios
Table 21: Japan size of population (million), 2012-16
Table 22: Japan gdp (constant 2005 prices, $ billion), 2012-16
Table 23: Japan gdp (current prices, $ billion), 2012-16
Table 24: Japan inflation, 2012-16
Table 25: Japan consumer price index (absolute), 2012-16
Table 26: Japan exchange rate, 2012-16


List of Figures
Figure 1: Japan biotechnology industry value: $ billion, 2012-16(e)
Figure 2: Japan biotechnology industry category segmentation: % share, by value, 2016(e)
Figure 3: Japan biotechnology industry geography segmentation: % share, by value, 2016(e)
Figure 4: Japan biotechnology industry value forecast: $ billion, 2016-21
Figure 5: Forces driving competition in the biotechnology industry in Japan, 2016
Figure 6: Drivers of buyer power in the biotechnology industry in Japan, 2016
Figure 7: Drivers of supplier power in the biotechnology industry in Japan, 2016
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Japan, 2016
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Japan, 2016
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Japan, 2016
Figure 11: Astellas Pharma Inc.: revenues and profitability
Figure 12: Astellas Pharma Inc.: assets and liabilities
Figure 13: Daiichi Sankyo Co., Ltd.: revenues and profitability
Figure 14: Daiichi Sankyo Co., Ltd.: assets and liabilities
Figure 15: Mitsubishi Tanabe Pharma Corporation: revenues and profitability
Figure 16: Mitsubishi Tanabe Pharma Corporation: assets and liabilities
Figure 17: Takeda Pharmaceutical Company Limited: revenues and profitability
Figure 18: Takeda Pharmaceutical Company Limited: assets and liabilities

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Transfection Reagents and Equipment Market by Method, Physical, Viral, Application, End User - Global Forecast to 2021

Transfection Reagents and Equipment Market by Method, Physical, Viral, Application, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global transfection reagents and equipment market is expected to reach USD 1.02 billion by 2021 from USD 715.4 million in 2016, at a CAGR of 7.5% during the forecast period 2016 to 2021. Over the years, ...

Humanized Mouse Model Market by Type, Application & End User - Global Forecast to 2021

Humanized Mouse Model Market by Type, Application & End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The humanized mouse model market is projected to reach USD 116.0 million by 2021 from USD 73.3 million in 2016, growing at a CAGR of 9.6% in the next five years (2016 to 2021). Growing adoption of personalized ...

Rat Model Market by Model Type, Technology, Therapeutic Area, Service, Care Products & End User -Global Forecast to 2021

Rat Model Market by Model Type, Technology, Therapeutic Area, Service, Care Products & End User -Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The rat model market is projected to reach USD 588.9 million by 2021 from USD 387.7 million in 2016, growing at a CAGR of 8.7% during the forecast period. Continuous support in the form of investments ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.